Barinthus Biotherapeutics plc (BRNS)
Official siteHEALTHCARE • BIOTECHNOLOGY • PINK
Market Cap: $30.23M
Last updated: Nov 16, 2026 at 4:00 PM ET
Barinthus Biotherapeutics plc (BRNS) Stock Chart
Barinthus Biotherapeutics (BRNS) closed at $0.74 on Nov 16, 2026, 12.9% below its 52-week high of $0.85. Its price fell 5.4% over the past 12 months. The month-end price fell 94.6% over the 5 years through Oct 2026, a compound annual decline of 44.3%.
Price Chart
From Apr 2021 to Oct 2026, its highest month-end close was $16.78 in Jun 2021 and its lowest $0.56 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BRNS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BRNS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 19.4%, and over 6 months it rose 15.9%. The month-end price fell 82.4% over the 3 years through Oct 2026, a compound annual decline of 43.9%.
| Period | Change |
|---|---|
| 1 month | 0.0% |
| 3 months | +19.4% |
| 6 months | +15.9% |
| 12 months | -5.4% |
| 12 months, with dividends | -5.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -82.4% | -43.9% |
| 5 years | -94.6% | -44.3% |
Price by Year
Its best calendar year was 2023, when the price rose 57.0%, and its weakest was 2022, when it fell 78.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.74 | +5.7% |
| 2025 | $0.70 | -42.0% |
| 2024 | $1.21 | -67.3% |
| 2023 | $3.69 | +57.0% |
| 2022 | $2.35 | -78.8% |
Trading Range
The price is at its 50-day average of $0.74 and 11.8% above its 200-day average of $0.66.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $0.74 | |
| 52-week high | $0.85 | -12.9% |
| 52-week low | $0.51 | +44.6% |
| 50-day average | $0.74 | 0.0% |
| 200-day average | $0.66 | +11.8% |
Price Risk
Over 3 years, its largest fall from a peak was 85.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.73 |
| Largest fall, 1 year | -32.1% |
| Largest fall, 3 years | -85.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BRNS
What is BRNS's 1-year price change?
Barinthus Biotherapeutics's price fell 5.4% over the past 12 months. With dividends included, the 12-month total return was -5.4%.
What is BRNS's 5-year price change?
Barinthus Biotherapeutics's month-end price fell 94.6% over the 5 years through Oct 2026, a compound annual decline of 44.3%. These figures leave out dividends.
What is BRNS's 52-week high and low?
Barinthus Biotherapeutics's 52-week high is $0.85 and its 52-week low is $0.51. Its close of $0.74 on Nov 16, 2026 is 12.9% below the high.
What is BRNS's beta?
Barinthus Biotherapeutics's 1-year beta against the S&P 500 is 0.73, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 32.1%.
Is the BRNS chart free?
Yes. Advanced Charting for BRNS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BRNS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors